-

    

Health Innovation in Action: Nanomedicine, Diagnostics and Smarter Policies 1/2

     
   18 Sept. clessidra che gira 11:30 - 13:00
ROOM 15
energy
HEALTH & NANOMEDICINE
TT.VI - Technical Parallel Track Sessions
Health Innovation in Action: Nanomedicine, Diagnostics and Smarter Policies 1/2
Co-organized with University of Modena and Reggio Emilia | Don Gnocchi Foundation
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia | Marzia BEDONI, Don Gnocchi Foundation

A journey through the latest advances in nanomedicine, targeted drug delivery, and innovative diagnostics, alongside a discussion on how evidence-based policies can support their integration into healthcare. The event connects cutting-edge research with practical applications, highlighting the role of technology, collaboration, and policy in shaping a smarter, more effective, and patient-centered health system for the future.

The symposium is part of WS.IX
TT.VI.E.1
WS.IX.2.1
Gabriella COSTABILE - CV
University of Naples, Federico II
Targeting the CD105/Endoglin Pathway in Pulmonary Fibrosis via Inhalable siRNA Delivered by pH-Responsive Lipid@PLGA hybrid Nanoparticles
Gabriella COSTABILE  
TT.VI.E.2
WS.IX.2.2
Ivana D'ANGELO - CV
University of Campania, Luigi Vanvitelli
Inhalable nanoparticles for antimicrobial peptide delivery in lung infections
DANGELO Ivana  
TT.VI.E.3
WS.IX.2.3
Maria Gioia FABIANO - CV
Sapienza University of Rome
Exploring Safety-by-Design: physicochemical properties and ecotoxicological evaluation of thyme oil-based nanocarriers
FABIANO Maria Gioia  
TT.VI.E.4
WS.IX.2.4
Ilaria OTTONELLI - CV
University of Modena and Reggio Emilia
Gene Delivery Nanomedicine Platform
OTTONELLI Ilaria  
TT.VI.E.5
WS.IX.2.5
Hiba NATSHEH - CV
An-Najah National University
Enhanced transdermal delivery and therapeutic effect of caryophyllene oxide via topical application in a transethosomal system
NATSHEH Hiba  
 

 

 
freccia SX f54 Back to Fields & Topics Back to Plan 18 September freccia DX f54
 

 

INFO & CONTACTS

This email address is being protected from spambots. You need JavaScript enabled to view it.